FARGO, N.D.--(BUSINESS WIRE)-- Aldevron, a global leader in the production of DNA, RNA and protein, has launched its latest innovation, Alchemy™ cell-free DNA technology. This revolutionary technology ...

By joining forces, IDT will pair its nearly 40-year legacy of quality and service, as well as its global presence, with ...

In January, Aldevron unveiled its Alchemy cell-free DNA technology. Instead of using cells to produce DNA, Alchemy relies on enzymes to produce linear DNA that serves as a template for the synthesis ...

Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot ...

Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis Telesis Bio, a leading provider of DNA and mRNA synthesis ...

Please provide your email address to receive an email when new articles are posted on . Biopsies with high donor-derived cell-free DNA levels were likely to reveal antibody-mediated rejection.

Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...